Health & Wellness

Founder Targets $50B GLP-1 Market with Natural Alternative

In a $50 billion GLP-1 market dominated by injectables like Ozempic, Becca McCarthy is carving out space with Evolv—a natural pill for appetite control. Teaming with a molecular biologist, she's delivering GLP-1-like effects without stigma or synthetics. Here's how she's challenging the prescription-only model.